Farmalac
Farmalac, officially known as Farmalac S.A., is a prominent player in the pharmaceutical and healthcare industry, headquartered in Massachusetts (MA). Established in 2005, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on the development of innovative formulations and generics. With a strong operational presence across North America and Europe, Farmalac is dedicated to enhancing patient care through its diverse range of core products, including prescription medications and over-the-counter solutions. What sets Farmalac apart is its commitment to rigorous quality standards and cutting-edge research, ensuring that its offerings meet the evolving needs of healthcare professionals and patients alike. Recognised for its market leadership, Farmalac has achieved notable milestones, including several industry awards for excellence in product development and customer service. As a trusted name in the pharmaceutical sector, Farmalac continues to drive advancements that contribute to better health outcomes globally.
DitchCarbon Score
How does Farmalac's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Paper Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Farmalac's score of 7 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Farmalac's reported carbon emissions
Farmalac, headquartered in Massachusetts (MA), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Farmalac has not outlined any specific reduction targets or commitments related to climate action. This lack of defined initiatives may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon reduction strategies. As the climate landscape evolves, it will be crucial for Farmalac to establish clear commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Farmalac is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
